Opportunity Information: Apply for PAR 18 605
The grant opportunity "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)" (Funding Opportunity Number PAR 18 605) is a National Institutes of Health (NIH) discretionary grant that supports transdisciplinary research aimed at improving how clinicians and researchers measure cognitive changes that can occur after cancer treatment, commonly referred to as "chemobrain." The central idea is to bring cognitive neuroscience tools and concepts into survivorship research so that cognitive impairment is not only detected more reliably, but also characterized in a way that makes clinical assessments more meaningful and useful for patient care.
This FOA focuses on cognitive changes following exposure to adjuvant chemotherapy and newer molecularly targeted treatments, including hormonal therapy, in people treated for non-central nervous system tumors. In practice, that means the program is concerned with cognitive outcomes among survivors whose cancer is not in the brain or spinal cord, but who may still experience attention, memory, executive function, processing speed, or other thinking-related difficulties during treatment (acute effects) or months to years afterward (late effects). By encouraging studies that clarify the timing, nature, and mechanisms of these changes, the NIH is signaling an interest in better clinical assessment protocols that can feed into stronger survivorship care plans, such as monitoring schedules, referral pathways, and tailored supportive interventions.
A key feature of the opportunity is its emphasis on improving "traditional measurement" of cognitive impairment. Many standard approaches rely on brief screening tools, self-report questionnaires, or neuropsychological tests that may not capture subtle, treatment-related shifts in cognition or may fail to connect test performance to real-world functioning. The FOA therefore encourages applicants to leverage cognitive neuroscience approaches that can refine measurement, improve sensitivity, and better link observed deficits to underlying cognitive processes. While the announcement does not prescribe specific methods in the provided text, the framing strongly suggests interest in approaches that can disentangle domains of cognition, identify specific processing deficits, and support more precise, clinically actionable assessment strategies. The mechanism is R01, which typically supports substantial multi-year research projects, and the FOA is "clinical trial optional," meaning applicants may propose either observational/mechanistic studies or clinical trial designs if appropriate to the research aims.
In terms of administrative details, this is a grant (Funding Instrument Type: Grant) in the Education and Health activity area, with CFDA number 93.395. The original closing date listed is April 11, 2019, and the creation date is January 30, 2018. An award ceiling and expected number of awards are not specified in the source information provided, which usually means applicants would need to consult the full FOA and NIH institute budgets to understand typical award sizes and paylines.
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other entities. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility aligns with the transdisciplinary intent of the program and supports partnerships among academic researchers, healthcare systems, community organizations, and other stakeholders involved in survivorship.
Overall, the opportunity is designed to push the field beyond broad or inconsistent definitions of post-treatment cognitive impairment by grounding assessment in cognitive neuroscience. The anticipated payoff is better detection and characterization of cognitive effects related to chemotherapy, hormonal therapy, and targeted treatments in non-CNS cancer survivors, ultimately enabling clinicians to monitor cognition more effectively and incorporate clearer guidance into survivorship care planning.Apply for PAR 18 605
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395.
- This funding opportunity was created on 2018-01-30.
- Applicants must submit their applications by 2019-04-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
Previous opportunity: Women’s Business Center - Initial Phase Grant
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 605
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 605) also looked into and applied for these:
| Funding Opportunity |
|---|
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional) Apply for PA 18 601 Funding Number: PA 18 601 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) Apply for PA 18 602 Funding Number: PA 18 602 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 18 606 Funding Number: PAR 18 606 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed) Apply for RFA GM 18 002 Funding Number: RFA GM 18 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) Apply for PAR 18 612 Funding Number: PAR 18 612 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional) Apply for PAR 18 611 Funding Number: PAR 18 611 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) Apply for PAS 18 624 Funding Number: PAS 18 624 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional) Apply for PAS 18 625 Funding Number: PAS 18 625 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 626 Funding Number: PA 18 626 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| NIDA Academic Research Enhancement Award (R15, Clinical Trials Required) Apply for PA 18 627 Funding Number: PA 18 627 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PA 18 629 Funding Number: PA 18 629 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,999 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 634 Funding Number: PA 18 634 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional) Apply for PAR 18 638 Funding Number: PAR 18 638 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Apply for PAR 18 641 Funding Number: PAR 18 641 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Apply for PAR 18 640 Funding Number: PAR 18 640 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed) Apply for RFA MD 18 006 Funding Number: RFA MD 18 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional) Apply for PAR 18 639 Funding Number: PAR 18 639 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Apply for PAR 18 645 Funding Number: PAR 18 645 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) Apply for PAR 18 644 Funding Number: PAR 18 644 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 18 011 Funding Number: RFA CA 18 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 605", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.